MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Impairment of goodwill$4,639K Deferred revenue$3,700K Net income$1,569K Proceeds from notepayable$3,622K Accrued expenses andother liabilities$1,456K Accounts and otherreceivables-$925K Depreciation andamortization$858K Provision for creditlosses and commission...$813K Accounts payable$600K Other long-termliabilities$490K Loss from investmentin eecp global-$408K Inventories-$86K Share-based compensation$33K Net cash provided byoperating activities$9,273K Net cash provided by(used in) financing...$248K Canceled cashflow$6,304K Canceled cashflow$3,374K Net increase in cashand cash...$8,779K Canceled cashflow$742K Deferred income taxes-$3,050K Gain on sale ofsubsidiary$827K Other assets, net$777K Accrued commissions-$541K Due from relatedparties$494K Prepaid expenses andother current assets$380K Deferred commissionexpense-$171K Income taxes payable-$60K Sales tax payable-$4K Proceeds from sale ofvasohealthcare it corp$200K Repayment of notes payableand finance lease...$3,373K Payroll taxes paid bywithholding shares$1K Net cash (used in)provided by investing...-$725K Effect of exchange ratedifferences on cash and cash...-$17K Canceled cashflow$200K Purchases of equipment andsoftware$925K
Cash Flow
source: myfinsight.com

VASO Corp (VASO)

VASO Corp (VASO)